Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.93 USD | -1.60% | +0.91% | +12.80% |
13/05 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
10/05 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- Official Publications